Clinical Trial Update: The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a novel in vivo device for detecting circulating tumor cells in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Beijing Viroad Biotechnology Co., Ltd. | Conditions: Circulating Tumor Cells.Breast | Phase 3 | Status: UNKNOWN